SL
Therapeutic Areas
Windmill Cardiovascular Systems Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TORVAD | End-Stage Heart Failure (Full Support) | Pre-clinical |
| TORVAD mini | Adult Heart Failure (Partial Support) | Pre-clinical |
| TORVAD Pediatric | Pediatric Heart Failure | Pre-clinical |
Leadership Team at Windmill Cardiovascular Systems
RS
Richard Smalling
CEO, Co-Founder
MK
Mark Kurusz
President
BJ
Bill James
Chief Business and Financial Advisor